Table I.
Characteristics of the groups
| Parameter | Group A Gentamicin + |
Group B Gentamicin – |
Value of p |
|---|---|---|---|
| Number of patients | 22 | 23 | |
| Women, n (%) | 4 (18) | 8 (35) | NS |
| Age, median (min.–max.) [years] | 61 (43–89) | 63 (33–83) | NS |
| RTG osteomyelitis, n (%) | 9 (41) | 15 (65) | NS |
| Diabetes type one, n (%) | 4 (18) | 3 (13) | NS |
| Diabetes duration, median (min.–max.) [years] | 19 (5–47) | 23 (2–54) | NS |
| Vascular intervention, n (%) | 11 (50) | 14 (61) | NS |
| Ischaemic heart disease, n (%) | 8 (36) | 6 (26) | NS |
| Hypertension, n (%) | 13 (59) | 15 (65) | NS |
| Renal insufficiency, n (%) | 5 (23) | 7 (30) | NS |
| TcPO2, median (min.–max.) [mm Hg] | 44 (13–67) | 48 (11–69) | NS |
| HbA1c, median (min.–max.) (%) | 6.0 (4.6–9.5) | 6.2 (4.0–8.4) | NS |
| Albumin, median (min.–max.) [g/l] | 33 (24–42) | 34 (22–42) | NS |
| Creatinine, median (min.–max.) [µmol/l] | 108 (58–700) | 98 (50–260) | NS |
| White blood cell count, median (min.–max.) (× 109/l) | 7.8 (5.7–13.0) | 7.5 (5.4–14.0) | NS |
| C-reactive protein, median (min.–max.) [mg/l] | 5 (1–130) | 10 (2–120) | NS |
NS – not significant difference, TcPO2 – transcutaneous oxygen tension, HbA1c – haemoglobin A1c percentage